Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

EVERYDAY LIFE EXPERIENCES IN FAMILIES WITH A CHILD WITH KIDNEY DISEASE.

Agerskov H, Thiesson HC, Pedersen BD.

J Ren Care. 2019 Aug 27. doi: 10.1111/jorc.12297. [Epub ahead of print]

PMID:
31453665
2.

Effect of spironolactone for 1 yr on endothelial function and vascular inflammation biomarkers in renal transplant recipients.

Mortensen LA, Bistrup C, Stubbe J, Carlström M, Checa A, Wheelock CE, Palarasah Y, Bladbjerg EM, Thiesson HC, Jensen BL.

Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F529-F539. doi: 10.1152/ajprenal.00025.2019. Epub 2019 Jun 5.

PMID:
31166706
3.

Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.

Fialla AD, Schaffalitzky de Muckadell OB, Bie P, Thiesson HC.

BMC Nephrol. 2018 Sep 19;19(1):238. doi: 10.1186/s12882-018-1039-6.

4.

The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).

Mortensen LA, Thiesson HC, Tougaard B, Egfjord M, Fischer ASL, Bistrup C.

BMC Nephrol. 2018 May 3;19(1):105. doi: 10.1186/s12882-018-0885-6.

5.

Identification of differential gene expression patterns in human arteries from patients with chronic kidney disease.

Stubbe J, Skov V, Thiesson HC, Larsen KE, Hansen ML, Jensen BL, Jespersen B, Rasmussen LM.

Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1117-F1128. doi: 10.1152/ajprenal.00418.2017. Epub 2018 Feb 7.

6.

Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?

Mortensen LA, Bistrup C, Thiesson HC.

Front Med (Lausanne). 2017 Nov 24;4:210. doi: 10.3389/fmed.2017.00210. eCollection 2017. Review.

7.

Internal dysregulation of the renin system in patients with stable liver cirrhosis.

Fialla AD, Thiesson HC, Bie P, Schaffalitzky de Muckadell OB, Krag A.

Scand J Clin Lab Invest. 2017 Jul;77(4):298-309. doi: 10.1080/00365513.2017.1308546. Epub 2017 Apr 18.

PMID:
28417649
8.

The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients.

Madsen MJ, Bergmann TK, Brøsen K, Thiesson HC.

Drugs R D. 2017 Jun;17(2):279-286. doi: 10.1007/s40268-017-0177-9.

9.

Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.

Engberg H, Wehberg S, Bistrup C, Heaf J, Sørensen SS, Thiesson HC, Hansen JM, Svensson M, Green A, Marckmann P.

Nephrol Dial Transplant. 2016 Dec;31(12):2149-2156. Epub 2016 Sep 1.

PMID:
27587604
10.

The second report of the Nordic Pediatric Renal Transplantation Registry 1997-2012: More infant recipients and improved graft survivals.

Jahnukainen T, Bjerre A, Larsson M, Tainio J, Thiesson HC, Jalanko H, Schwartz Sørensen S, Wennberg L.

Pediatr Transplant. 2016 May;20(3):364-71. doi: 10.1111/petr.12686. Epub 2016 Feb 9.

PMID:
26857893
11.

Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.

Maksten EF, Vase MØ, Kampmann J, d'Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B.

Transpl Int. 2016 Apr;29(4):483-93. doi: 10.1111/tri.12744. Epub 2016 Feb 18.

12.

Factors predicting kidney damage in Puumala virus infected patients in Southern Denmark.

Skarphedinsson S, Thiesson HC, Shakar SA, Tepel M.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2017-21. doi: 10.1007/s10096-015-2446-2. Epub 2015 Jul 24.

PMID:
26205664
13.

Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth.

Wittenhagen P, Thiesson HC, Baudier F, Pedersen EB, Neland M.

Pediatr Transplant. 2014 Feb;18(1):35-41. doi: 10.1111/petr.12186. Epub 2013 Nov 20.

PMID:
24384046
14.

The renal arterial resistive index and stage of chronic kidney disease in patients with renal allograft.

Winther SO, Thiesson HC, Poulsen LN, Chehri M, Agerskov H, Tepel M.

PLoS One. 2012;7(12):e51772. doi: 10.1371/journal.pone.0051772. Epub 2012 Dec 14.

15.

[Renal failure in a couple caused by Puumala hantavirus].

Redal-Baigorri B, Thiesson HC, Skarphedinsson S.

Ugeskr Laeger. 2012 Oct 29;174(44):2714-5. Danish.

PMID:
23121909
16.

The role of glucocorticoids in sodium retention in cirrhotic patients: a double blind, randomized, crossover study.

Højmark Hansen M, Kristensen SS, Schaffalitzky de Muckadell OB, Thiesson HC, Andrew R, Dam Fialla A.

Scand J Gastroenterol. 2012 Sep;47(8-9):1030-6. doi: 10.3109/00365521.2012.690044. Epub 2012 Jun 7.

PMID:
22670598
17.

Vitamin D status in children and adolescents with kidney transplants.

Brodersen LA, Nielsen PR, Thiesson HC, Marckmann P.

Pediatr Transplant. 2011 Jun;15(4):384-9. doi: 10.1111/j.1399-3046.2011.01493.x. Epub 2011 Mar 2.

PMID:
21366811
18.

Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.

McNeilly AD, Macfarlane DP, O'Flaherty E, Livingstone DE, Mitić T, McConnell KM, McKenzie SM, Davies E, Reynolds RM, Thiesson HC, Skøtt O, Walker BR, Andrew R.

J Hepatol. 2010 May;52(5):705-11. doi: 10.1016/j.jhep.2009.10.037. Epub 2010 Mar 4.

19.

Differential effects of immunosuppressive drugs on COX-2 activity in vitro and in kidney transplant patients in vivo.

Jespersen B, Thiesson HC, Henriksen C, Therland K, Falk C, Poulsen T, Fogh B, Madsen K, Walther S, Jensen BL.

Nephrol Dial Transplant. 2009 May;24(5):1644-55. doi: 10.1093/ndt/gfp004. Epub 2009 Feb 4.

PMID:
19193738
20.

Plasmin in nephrotic urine activates the epithelial sodium channel.

Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O.

J Am Soc Nephrol. 2009 Feb;20(2):299-310. doi: 10.1681/ASN.2008040364. Epub 2008 Dec 10.

21.

Report of the first human case of Caulobacter sp. infection.

Justesen US, Holt HM, Thiesson HC, Blom J, Nielsen XC, Dargis R, Kemp M, Christensen JJ.

J Clin Microbiol. 2007 Apr;45(4):1366-9. Epub 2007 Jan 31. Erratum in: J Clin Microbiol. 2007 Dec;45(12):4098.

22.

Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity.

Thiesson HC, Jensen BL, Bistrup C, Ottosen PD, McNeilly AD, Andrew R, Seckl J, Skøtt O.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R625-36. Epub 2006 Aug 17.

23.

Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.

Bistrup C, Thiesson HC, Jensen BL, Skøtt O.

Acta Physiol Scand. 2005 Jun;184(2):161-9.

PMID:
15916676
24.

Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.

Thiesson HC, Jensen BL, Jespersen B, Schaffalitzky de Muckadell OB, Bistrup C, Walter S, Ottosen PD, Veje A, Skøtt O.

Am J Physiol Renal Physiol. 2005 May;288(5):F1044-52. Epub 2004 Dec 21.

25.

Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors.

Therland KL, Stubbe J, Thiesson HC, Ottosen PD, Walter S, Sørensen GL, Skøtt O, Jensen BL.

J Am Soc Nephrol. 2004 May;15(5):1189-98.

26.

Expression of adrenomedullin in hypoxic and ischemic rat kidneys and human kidneys with arterial stenosis.

Sandner P, Hofbauer KH, Tinel H, Kurtz A, Thiesson HC, Ottosen PD, Walter S, Skøtt O, Jensen BL.

Am J Physiol Regul Integr Comp Physiol. 2004 May;286(5):R942-51. Epub 2004 Jan 8.

27.

Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.

Thiesson HC, Skøtt O, Jespersen B, Schaffalitzky de Muckadell OB.

Am J Gastroenterol. 2003 Jan;98(1):180-6.

PMID:
12526955

Supplemental Content

Loading ...
Support Center